Jump to content

Publication: Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer

From CAMIH
Revision as of 14:04, 16 July 2024 by DDeel (talk | contribs) (Created page with "{{Publication |Title=Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer |Topic=Vitamin C, Vitamin E |Author=Chung, MK; Kim, DH; Ahn, YC; Choi, JY; Kim, EH; Son, YI |Year=2016 |Journal=Otolaryngology – Head and Neck Surgery |DOI=https://doi.org/10.1177/0194599816642418 |Authors Abstract=Objective. The present study was conducted to determine the preventive efficacy of vitamin C/E complex suppleme...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Reference
Title Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer
Topic Vitamin C, Vitamin E
Author Chung, MK, Kim, DH, Ahn, YC, Choi, JY, Kim, EH, Son, YI
Year 2016
Journal Otolaryngology – Head and Neck Surgery
DOI https://doi.org/10.1177/0194599816642418

Author's Abstract The abstract and the information and conclusions contained therein were written by the authors of the publication.

Objective. The present study was conducted to determine the preventive efficacy of vitamin C/E complex supplementation for radiotherapy (RT)–induced xerostomia in patients with head and neck cancer.

Study Design. Prospective, double-blinded, randomized, placebo-controlled study.

Setting. A single tertiary referral institution.

Subjects and Methods. The trial group (n = 25) received antioxidant supplements (100 IU of vitamin E 1 500 mg of vitamin C) twice per day during RT, while the control group (n = 20) received an identical placebo. Pre-RT and 1 and 6 months post-RT, patient-reported xerostomia questionnaires, observer-rated xerostomia score, and salivary scintigraphy were serially obtained to compare xerostomia severity between the 2 groups.

Results. The trial group showed greater improvements in xerostomia questionnaire and score at 6 months post-RT when compared with those at 1 month post-RT (P = .007 and .008, respectively). In contrast, the control group showed no changes between 1 and 6 months post-RT. By salivary scintigraphy, there was no difference in maximal accumulation or ejection fraction between the 2 groups. However, the trial group maintained significantly better oral indices at the prestimulatory (P = .01) and poststimulatory (P = .009) stages at 1 month post-RT, compared with the control group. At the final follow-up, there was no difference in overall survival and disease-free survival between the 2 groups.

Conclusions. Our data suggest that short-term supplementation with an antioxidant vitamin E/C complex exerts a protective effect against RT-induced xerostomia.



This publication is referenced in the following studies:

  1. Chung et al. (2016): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer